Quarters are matched automatically on the comparison year: pick once, both periods stay aligned.
| Line item | FY2026 (Q2) | FY2025 (Q2) |
|---|---|---|
| Revenue | $70.06B | $44.82B |
| COGS | $36.61B | $26.86B |
| Gross Profit | — | — |
| R&D | $0 | $0 |
| SG&A | $1.31B | $889M |
| D&A | $6.08B | $4.34B |
| Other OpEx | $256M |
QuarterCharts · SEC EDGAR data · CVX · Comparing FY2026 (Q2) vs FY2025 (Q2)
| $252M |
| Operating Income | — | — |
| Interest Exp. | $352M | $274M |
| Other Non-Op | — | — |
| Non-Op Income | — | — |
| Costs not shown separately | $8.76B | $8.06B |
| Pretax Income | $16.68B | $4.15B |
| Tax | $4.47B | $1.63B |
| Other (Below Tax) | $0 | $0 |
| Other Income (After Tax) | $0 | $0 |
| Tax Benefit | $0 | $0 |
| Net Income Consolidated | $12.21B | $2.52B |
| Noncontrolling Interest | $142M | $25M |
| Net Income | $12.07B | $2.49B |